CNSIG Inner Mongolia Chemical Industry (600328.SH) subsidiary's safety production permit has expired and production has been suspended.
China Salt Chemical (600328.SH) announced that its wholly-owned subsidiary, Zhongyan Kunshan Co., Ltd. (referred to as "Zhongyan Kunshan"), has received a "Decision on On-Site Handling Measures" from the Kunshan Emergency Management Bureau. According to the annual plan, starting from March 22, 2026, Zhongyan Kunshan's production unit will undergo annual shutdown and maintenance. On March 27, 2026, Zhongyan Kunshan received a "Decision on On-Site Handling Measures" from the Kunshan Emergency Management Bureau due to the expiration of its "Safety Production License," notifying it to temporarily suspend production starting from March 27, 2026.
CNSIG Inner Mongolia Chemical Industry (600328.SH) announced that its wholly-owned subsidiary Kunshan China National Salt Industry Group Co., Ltd. (referred to as "Kunshan China National Salt Industry Group") received a "Decision on Site Handling Measures" from the Kunshan Emergency Management Bureau. According to the annual plan, Kunshan China National Salt Industry Group's production facilities will undergo annual shutdown and maintenance starting from March 22, 2026. On March 27, 2026, as its "Safety Production License" expired, Kunshan China National Salt Industry Group received a "Decision on Site Handling Measures" from the Kunshan Emergency Management Bureau, notifying them to temporarily suspend production starting from March 27, 2026.
Related Articles

On March 30, STANCHART (02888) spent 14.95 million British pounds to repurchase 974,400 shares.

"China Resources Gas (01193) spent 81.7938 million Hong Kong dollars to repurchase 433.48 million shares on March 31."

CK Life Sciences (00775) subsidiary SunPur Medicine Technology will present research data on the development of therapeutic cancer vaccines at the AACR 2026 Annual Meeting.
On March 30, STANCHART (02888) spent 14.95 million British pounds to repurchase 974,400 shares.

"China Resources Gas (01193) spent 81.7938 million Hong Kong dollars to repurchase 433.48 million shares on March 31."

CK Life Sciences (00775) subsidiary SunPur Medicine Technology will present research data on the development of therapeutic cancer vaccines at the AACR 2026 Annual Meeting.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


